Aimmune Therapeutics Appoints Jeffrey H. Knapp as Chief Operating Officer by longitudeadmin | Dec 17, 2015 | Portfolio NewsAimmune Therapeutics Appoints Jeffrey H. Knapp as Chief Operating Officer
Collegium Announces Publication of Nasal Human Abuse Potential Study in American Academy of Pain Medicine by longitudeadmin | Dec 16, 2015 | Portfolio News
Practice Fusion Expands Executive Team with Hiring of New Chief Operating Officer; Promotes New Senior VP of Product Management by longitudeadmin | Dec 16, 2015 | Portfolio News
Corcept Therapeutics Announces Initial Efficacy Results in Phase 1/2 Trial of Mifepristone in Combination With Eribulin for the Treatment of Patients With Metastatic Triple-Negative Breast Cancer by longitudeadmin | Dec 14, 2015 | Portfolio News
Timothy Henn, Experienced Genomics Diagnostics and Life Sciences Executive, Joins CardioDx as Chief Financial Officer by longitudeadmin | Dec 14, 2015 | Portfolio News
